To be honest - I was expecting even more of Pfizer's money to have been spent than this. Of course there has been no real growth in the actual core business - our board have been too busy trying to convince everyone to give the business and their investments away...
Seriously - anybody in their actual right and logical mind can see the enormous potential of this technology and business.
If only we had competent and professional leaders, with experience in global health-tech commercialisation, who are genuinely dedicated to pro-actively advancing and commercialising the company, and acting not only in the best interests of shareholders, but also passionate about the implementation of what clearly is, and should be, such critically important and useful contemporary technology for today's world.
A large-scale global partner would of course be helpful too.
Where things have ended up for this company is so frustrating and disappointing. And, in my opinion, the burden of that responsibility lies completely in the failure of management - at so many critical junctures in the journey of this company.
How unsurprising that our conference call is postponed. Such a disappointment.
- Forums
- ASX - By Stock
- RAP
- Ann: Quarterly Activities Report and Appendix 4C
Ann: Quarterly Activities Report and Appendix 4C, page-26
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online